| Literature DB >> 36009342 |
Shabnam Shabir1, Sumaira Yousuf1, Sandeep Kumar Singh2, Emanuel Vamanu3, Mahendra P Singh1.
Abstract
Natural antioxidants derived from plants have been proven to have significant inhibitory effects on the free radicals of living organisms during actively metabolization. Excessive production of free radicals increases the risk of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and motor sclerosis. This study aimed to compare the ethnopharmacological effects of Urtica dioica (UD), Matricaria chamomilla (MC), and Murraya koenigii (MK) on the amelioration of rotenone-induced toxicity in wild-type Drosophila melanogaster (Oregon R+) at biochemical, cellular, and behavioral levels. Phytoextracts were prepared from all three plants, i.e., UD, MC, and MK (aqueous and ethanolic fractions), and their bioactive compounds were evaluated using in vitro biochemical parameters (DPPH, ABTS, TPC, and TFC), UV-Vis, followed by FT-IR and HPLC. Third instar larvae and freshly eclosed flies were treated with 500 µM rotenone alone or in combination with UD, MC, and MK for 24 to 120 h. Following exposure, cytotoxicity (dye exclusion test), biochemical (protein estimation and acetylcholinesterase inhibition assays), and behavioral assays (climbing and jumping assays) were performed. Among all three plant extracts, MK exhibited the highest antioxidant properties due to the highest TPC, TFC, DPPH, and ABTS, followed by UD, then MC. The overall trend was MK > UD > MC. In this context, ethnopharmacological properties mimic the same effect in Drosophila, exhibiting significantly (p < 0.05) reduced cytotoxicity (trypan blue), improved biochemical parameters (proteotoxicity and AChE activity), and better behavioral parameters in the organisms cotreated with phyto extracts compared with rotenone. Conclusively, UV-Vis, FTIR, and HPLC analyses differentiated the plant extracts. The findings of this research may be beneficial in the use of select herbs as viable sources of phyto-ingredients that could be of interest in nutraceutical development and various clinical applications.Entities:
Keywords: 1,1-diphenyl-2-picrylhydrazyl; HPLC; acetylcholinesterase; antioxidants; medicinal plants; oxidative stress
Year: 2022 PMID: 36009342 PMCID: PMC9405140 DOI: 10.3390/antiox11081623
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
The percentage yield of plant extracts using aqueous and ethanolic extraction methods.
| S. No. | Plant Species | Code | Plant Part Used | Solvents (%) Yield ( | |
|---|---|---|---|---|---|
| Aqueous Extracts | Ethanolic Extracts | ||||
| 1. |
| UD | Leaves | 14.34 | 10.45 |
| 2. |
| MC | Flower | 8.56 | 14.68 |
| 3. |
| MK | Leaves | 21.62 | 15.27 |
Figure 1The effect of different concentrations of U. dioica (UD), M. chamomilla (MC), and M. koenigii (MK) in (a,b) aqueous and (c,d) ethanolic extractions on the (a,c) DPPH and (b,d) ABTS free radical scavenging assay. Data represent mean ± SD for n = 3. Statistically significance ascribed as * p < 0.05 (intragroup) and # p < 0.05 (intergroup) compared with 0.5 mg/mL and 0.1 mg/mL of the respective groups.
Figure 2Dose-response profiles of the estimated EC50 (mg/mL) of (a,c) aqueous and (b,d) ethanolic extracts of U. dioica (UD), M. chamomilla (MC), and M. koenigii (MK) on the (a,b) DPPH and (c,d) ABTS assays.
Estimated EC50 (mg/mL) of UD, MC, and MK were obtained by different models using DPPH and ABTS assays.
| Assays | Plant Species | Plant Part Used | EC50 (mg/mL) of Aqueous Extracts | EC50 (mg/mL) of Ethanolic Extracts |
|---|---|---|---|---|
| DPPH | UD | Leaves | 0.42 | 0.16 |
| MC | Flowers | 1.00 | 0.12 | |
| MK | Leaves | 0.33 | 0.10 | |
| ABTS | UD | Leaves | 0.55 | 0.10 |
| MC | Flowers | 1.04 | 0.16 | |
| MK | Leaves | 0.51 | 0.07 |
Figure 3Total (a) phenolic and (b) flavonoid contents of aqueous and ethanolic fractions of U. dioica, M. chamomilla, and M. koenigii. Data are shown as the mean ± SD for n = 3. Statistical significance is ascribed as * p < 0.05 (intragroup) and # p < 0.05 (intergroup) of the respective groups.
TPC and TFC results of UD, MC, and MK are expressed in mean ± SD.
| Plant Species | Plant Part Used | TPC mg (GAE)/g (Aqueous) | TPC mg (GAE)/g (Ethanolic) | TFC mg (QE)/g (Aqueous) | TFC mg (QE)/g (Ethanolic) |
|---|---|---|---|---|---|
|
| Leaves | 26.08 ± 2.02 | 42.16 ± 2.06 | 5.458 ± 2.3 | 12.48 ± 1.04 |
|
| Flowers | 24.01 ± 1.50 | 40.5 ± 4.04 | 5.465 ± 1.06 | 12.64 ± 2.3 |
|
| Leaves | 35.14 ± 3.0 | 48.93 ± 2.03 | 9.641 ± 2.5 | 22.88 ± 1.05 |
Preliminary qualitative screening of secondary metabolites of crude extracts of UD, MC, and MK.
| S. No. | Phytoconstituents | Tests | Positive Results | UD | MC | MK |
|---|---|---|---|---|---|---|
| 1. | Phenols | Ferric chloride test | Bluish-green | + | + | + |
| 2. | Flavonoids | Alkaline reagent test | Orange-red | + | + | + |
| 3. | Alkaloids | Wagner’s test | Red precipitate | + | + | + |
| 4. | Tannins | FeCl3 test | Black blue | + | + | + |
| 5. | Carbohydrates | Molisch’s test | Red or dull violet | + | − | + |
| 6. | Saponins | Foam test | White precipitate | + | + | + |
| 7. | Terpenoids | Salkowski test | Change from pink to violet | + | + | + |
| 8. | Steroids | Liebermann’s test | violet to blue or green color | + | + | + |
| 9. | Glycosides | Keller-Killiani test | Brick red | − | + | + |
Note: The presence of phytoconstituents is indicated by a ‘+’ sign, whereas the lack of phytoconstituents is indicated by ‘−’.
Figure 4UV-Visible spectra of (a) UD, (b) MC, and (c) MK fractions. Red arrows represent the peak of extract (conjugated or chemical bonds). The FT-IR absorption spectrum of (d) UD, (e) MC, and (f) MK with a scan range of 400–4000 cm−1.
FT-IR frequency range and functional groups are present in the extracts of UD, MC, and MK.
| S. No. | Frequency Range (cm−1) | Functional Groups | Phytocompounds Identified | ||
|---|---|---|---|---|---|
| UD | MC | MK | |||
| 1. | 3358.28 | 3327.40 | 3307.88 | H-bonded, OH stretching | Hydroxyl compounds |
| 2. | 2923.25 | 2921.90 | 2974.04 | Asymmetric stretching | Saturated aliphatic Compounds (Lipids) |
| 3. | 2853.54 | 2802.86 | 2804.74 | Symmetric stretching | Proteins, lipids |
| 4. | 1698.70, | 1601.79 | 1611.44 | C=O stretching vibration | Ketone compound |
| 5. | 1455.85 | 1404.99 | - | C=C-C aromatic ring stretching | Aromatic compound |
| 6. | 1399.89 | - | 1396.51 | O-H, alcoholic group | Phenol or tertiary alcohol |
| 7. | - | 1271.82 | 1275.04 | CN stretching | Aromatic primary amine |
| 8. | 1160.88 | 1174.09 | 1140.63 | Polymeric OH, C-O stretching | Cyclic ether |
| 9. | 1055.84 | 1074.42, 1043.61 | 1044.62 | Phosphate ion | Phosphate compound |
| 10. | - | - | 877.47 | Aromatic phosphate | |
| 11. | 720.06 | 620.82 | 659.68 | C-Cl stretching | Aliphatic chloro compound |
Figure 5HPLC profiles acquired at 280 nm of (a) standard rutin and quercetin and ethanolic extracts obtained from (b) U. dioica leaves, (c) M. chamomilla flowers, and (d) M. koenigii leaves, showing different bioactive compounds. R stands for rutin, and Q stands for quercetin.
Major phytochemical compounds identified in ethanolic extracts of U. dioica, M. chamomilla, and M. koenigii.
| S. No | Retention Time (Rt min.) | Compound | Molecular Formulae | Chemical Structure | Molecular Weight (g/mol) | Pharmacological Actions | ||
|---|---|---|---|---|---|---|---|---|
| UD | MC | MK | ||||||
| 1. | 1.931 | - | 1.645 | Fumaric acid | C4H4O4 |
| 116.07 | Reduces gallstone formation, used for the treatment of multiple sclerosis and psoriasis. |
| 2. | 4.240 | 4.235 | 4.276 | Gallic acid | C7H6O5 |
| 170.12 | Expectorant, cytotoxic steroid, memory enhancer, anti-inflammatory, anti-neoplastic, and antioxidant properties. |
| 3. | - | 7.523 | 7.473 | Protocatechuic acid | C7H6O4 |
| 154.12 | Neuroprotective, antioxidant, anticancer, antibacterial, anti-aging, and anti-asthma properties. |
| 4. | 9.211 | - | 9.865 | Catechins | C15H14O6 |
| 290.27 | Used to prevent and treat various diseases, high antioxidant activity, and used in cosmetics. |
| 5. | - | 11.387 | - | 4-O-Caffeoylquinic acid | C16H18O9 |
| 354.31 | Cytoprotective, neuroprotective, and hepatoprotective effects. |
| 6. | 15.982 | 14.683 | 15.554 | Caffeic acid derivative | C9H8O4 |
| 180.16 | Prevents DNA damage and oxidative stress induced by free radicals. |
| 7. | 16.683 | 16.299 | 16.693 | Epicatechin | C15H14O6 |
| 290.27 | Reduces blood glucose levels in diabetic patients and stimulates mitochondrial respiration. |
| 8. | 17.248 | 17.558 | 17.280 | Rutin | C27H30O16 |
| 610.5 | Hypolipidemic, anti-protozoal, vasoactive, cytoprotective, anti-allergic, anti-platelet, anti-hypertensive, and anti-spasmodic properties. |
| 9. | 17.515 | 17.428 | 17.625 | Syringic acid | C9H10O5 |
| 198.17 | Used in the prevention of CVDs, cancer, diabetes, and possesses antioxidant activities. |
| 10. | 18.094 | 18.763 | 18.651 | Isorhamnetin-3-O-glucoside | C22H22O12 |
| 478.4 | Anti-viral, antioxidant, anticancer, anti-tumor, anti-inflammatory, and antimicrobial properties. |
| 11. | - | 19.243 | - | Apigenin-7-O-glucoside | C21H20O10 |
| 432.4 | Prominent chemopreventive, anti-candidal effect, antifungal potential, and strengthens the failing heart. |
| 12. | 20.728 | 20.152 | 20.835 | p-coumaric acid | C9H8O3 |
| 164.16 | Anti-inflammatory, antimicrobial, anti-viral, and antibacterial properties. |
| 13. | - | 21.739 | - | 4,5-O-dicaffeoylquinic acid | C25H24O12 |
| 516.4 | In melanocytes, significantly reduces tyrosinase activity and melanin synthesis in a dose-dependent manner. |
| 14. | 22.564 | 22.571 | 22.677 | 2-O-Caffeoylmalic acid | C13H12O8 |
| 296.230 | Prevents ROS production and possesses high antioxidant activity. |
| 15. | 23.232 | 23.924 | 23.232 | Ferulic acid | C10H10O4 |
| 194.18 | Wide range of therapeutic uses against various diseases including cancer, arthritis, etc. |
| 16. | - | 24.579 | - | Naringin | C27H32O14 |
| 580.5 | Anti-carcinogenic and acts as inhibitor of selected cytochrome P450 enzymes. |
| 17. | 25.247 | 25.460 | 25.814 | Quercetin (quercetin-3-O-rhamonoside) | C21H20O11 |
| 448.4 | Used in the treatment of inflammatory, allergic, and metabolic disorders and act as anti-protozoal. |
| 18. | 27.723 | 27.787 | 27.379 | Myricetin | C15H10O8 |
| 318.23 | Acts as an anti-epileptic, anti-amyloidogenic, anti-diabetic, antioxidant, antibacterial, anti-ulcer, antiviral, anticancer, and anti-inflammatory agent. |
| 19. | 28.231 | 28.789 | 29.031 | Quercetin | C21H20O11 |
| 448.4 | Decreases tumor necrosis factor (TNF-α) production in macrophages and LPS-driven IL-8 synthesis in lung A549 cells generated by lipopolysaccharide (LPS). |
| 20. | 32.156 | 32.956 | 31.456 | Kaempferol | C15H10O6 |
| 286.24 | Anxiolytic, anti-diabetic, anti-estrogenic, anti-osteoporotic, cardioprotective, and neuroprotective properties. |
| 21. | - | 34.320 | - | Luteolin | C15H10O6 |
| 286.24 | Exhibits anti-inflammatory properties due to ability to regulate transcription factors like NF-B, AP-1, and STAT3. |
| 22. | - | 34.745 | - | Cirsiliol | C17H14O7 |
| 330.29 | Act as inhibitor of arachidonate 5-lipoxygenase and has anticancer, hypnotic, sedative, and anti-inflammatory properties. |
| 23. | 35.339 | 35.445 | 36.021 | Isorhamnetin | C16H12O7 |
| 316.26 | Cerebrovascular and cardiovascular protective properties; in addition, has antioxidant, anti-tumor, anti-inflammatory, organ protection, and obesity prevention properties. |
| 24. | 37.277 | - | 37.552 | Kaempferol 3-O-glucoside | C21H14O11 |
| 448.38 | Lowers the risk of chronic diseases, particularly cancer, and boosts the body’s antioxidant defenses against free radicals. |
| 25. | 39.901 | 41.026 | 40.516 | Isorhamnetin 3-O-rutinoside | C28H32O16 |
| 624.5 | Inhibits membrane proteins and has anti-apoptosis, antioxidation, anti-tumor, anti-inflammation, antiviral, antibacterial, anti-amyloidogenic, and anti-diabetic properties. |
Figure 6Dye exclusion test through trypan blue staining in third instar larvae exposed to rotenone and cotreated with UD, MC, and MK, as shown in the upper panels. The lower panels show dissected third instar larvae stained with trypan blue. Seventy-two hour (±2 h) old larvae (early third instar) of D. melanogaster (Oregon R+) were exposed to ROT 500 µM alone or in combination with UD, MC, and MK for 48 h. Arrows of the upper panel show cytotoxicities in the whole larvae through trypan blue staining. Note: bg= brain ganglia, sg= salivary glands, pv= proventriculus, mg= midgut, mt= malpighian tubules, and hg = hind gut. The bar represents 100 μm. ROT= rotenone; UD = Urtica dioica, MC = Matricaria chamomilla and MK = Murraya koenigii.
Figure 7Total protein content in third instar larvae of D. melanogaster (Oregon R+) exposed to 500 µM rotenone for 24 and 48 h. Data represent the mean ± SD of three identical experiments made in three replicates. Significance is ascribed as * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control or DMSO control. # = significance at * p < 0.05 as compared with 500 µM rotenone. UD = Urtica dioica, MC = Matricaria chamomilla and MK = Murraya koenigii.
Figure 8Acetylcholinesterase activity in the third instar larvae of D. melanogaster (Oregon R+) exposed to 500 µM ROT alone or in combination with UD, MC, and MK for 24 and 48 h. Data represent mean ± SD (n = 3); significance ascribed as ** p < 0.01, *** p < 0.001 vs. control or DMSO control. # is ascribed as significance at p < 0.05, ### p < 0.001 as compared with 500 µM rotenone. UD = Urtica dioica, MC = Matricaria chamomilla and MK = Murraya koenigii.
Figure 9(A) Jumping and (B) climbing activity of D. melanogaster (Oregon R+) flies exposed to ROT 500 µM alone or in combination with UD, MC, and MK for 120 h; significance is ascribed as ** p < 0.01, *** p < 0.001 vs. control or DMSO control. ## ascribed as significance at p < 0.01, ### p < 0.001 compared with 500 µM rotenone. UD = Urtica dioica, MC = Matricaria chamomilla and MK = Murraya koenigii.